Endocrine Abstracts

Introduction: Multiple endocrine neoplasia type 2B (MEN 2B) is an aggressive disorder characterized by medullary thyroid cancer (MTC) and pheochromocytoma. Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE is an effective new treatment for inoperable or metastatic neuroendocrine tumors (NETs). Hematologic problems, myelodysplastic syndrome or leukemia can be seen after alkylating agent and peptide receptor radionuclide therapy treatments. We present metastatic m...